Telix jumps 11.6% as US government indicates proposed medicare changes won’t affect prostate cancer drug
Telix Pharmaceuticals (ASX:TLX) has announced its prostate cancer imaging drug Illuccix won’t…
Telix Pharmaceuticals Limited (ASX:TLX)
About Telix Pharmaceuticals Limited
Key Information
TLX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/07/2024 | Becoming a substantial holder | 957.25KB | 2.1K |
| 24/07/2024 | FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent | 138.37KB | 8.5K |
| 24/07/2024 | Appendix 3B | 754.68KB | 285 |
| 24/07/2024 | Price Sensitive PS Telix Successfully Prices A$650M Convertible Bonds | 142.09KB | 25K |
| 23/07/2024 | Telix Investor Presentation July 2024 | 1.74MB | 3.8K |
| 23/07/2024 | Price Sensitive PS Telix Announces A$600 Million Convertible Bonds Offering | 148.65KB | 14K |
| 18/07/2024 | Price Sensitive PS Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade | 205.77KB | 20K |
| 11/07/2024 | Price Sensitive PS CMS proposes payment improvement for radiopharma diagnostics | 136.9KB | 15K |